Edla, D.R. et al. 2024. Spesolimab: A Novel Interleukin-36 Receptor Monoclonal Antibody for the Treatment of Generalized Pustular Psoriasis. Asian Journal of Pharmaceutical Research and Development. 12, 3 (Jun. 2024), 88–93. DOI:https://doi.org/10.22270/ajprd.v11i3.1400.